The ethanolamide metabolite of DHA, docosahexaenoylethanolamine, shows immunomodulating effects in mouse peritoneal and RAW264.7 macrophages: Evidence for a new link between fish oil and inflammation

British Journal of Nutrition

Volumn 105, Issue 12, 2011, Pages 1798-1807

  Meijerink, Jocelijn ^a   Plastina, Pierluigi ^a   Vincken, Jean Paul ^a   Poland, Mieke ^a   Attya, Mohamed ^a   Balvers, Michiel ^a,b   Gruppen, Harry ^a   Gabriele, Bartolo ^c   Witkamp, Renger F ^a,b  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b TNO   (Netherlands)

^c UNIVERSITY OF CALABRIA   (Italy)

Author keywords

DHA; Docosahexaenoylethanolamine; Inflammation; Macrophages; Monocyte chemotactic protein 1; Nitric oxide

Indexed keywords

AMIDE; ANANDAMIDE; DOCOSAHEXAENOIC ACID; DOCOSAHEXAENOYL ETHANOLAMINE; DOCOSATETRAENOYLETHANOLAMINE; EICOSANPENTAENOYLETHANOLAMINE DERIVATIVE; FISH OIL; INDUCIBLE NITRIC OXIDE SYNTHASE; LINOLEOYLETHANOLAMINE DERIVATIVE; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; N ACYLETHANOLAMINE DERIVATIVE; N OLEOYLETHANOLAMINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHRONIC INFLAMMATION; DIET SUPPLEMENTATION; ENZYME INHIBITION; ENZYME RELEASE; ENZYME SYNTHESIS; IMMUNOMODULATION; INFLAMMATION; MACROPHAGE; MALE; MOUSE; NONHUMAN; PERITONEUM; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 79958768781     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114510005635     Document Type: Article

References (61)

1. Kilaru A, Blancaflor EB, Venables BJ, et al. (2007) The N-acylethanolamine-mediated regulatory pathway in plants. Chem Biodivers 4, 1933-1955. (Pubitemid 47377211)
2. Okamoto Y, Wang J, Morishita J, et al. (2007) Biosynthetic pathways of the endocannabinoid anandamide. Chem Biodivers 4, 1842-1857. (Pubitemid 47377206)
3. Borrelli F & Izzo AA (2009) Role of acylethanolamides in the gastrointestinal tract with special reference to food intake and energy balance. Best Prac Res Clin Endocrinol Metab 23, 33-49.
4. Alexander SPH & Kendall DA (2007) The complications of promiscuity: endocannabinoid action and metabolism. Br J Pharmacol 152, 602-623. (Pubitemid 350034984)
5. Di Marzo V, Bisogno T & De Petrocellis L (2007) Endocannabinoids and related compounds: walking back and forth between plant natural products and animal physiology. Chem Biol 14, 741-756. (Pubitemid 47081420)
6. Re G, Barbero R, Miolo A, et al. (2007) Palmitoylethanolamide, endocannabinoids and related cannabimimetic compounds in protection against tissue inflammation and pain: potential use in companion animals. Vet J 173, 21-30.
7. Hoareau L, Buyse M, Festy F, et al. (2009) Anti-inflammatory effect of palmitoylethanolamide on human adipocytes. Obesity 17, 431-438.
8. Thabuis C, Tissot-Favre D, Bezelgues JB, et al. (2008) Biological functions and metabolism of oleoylethanolamide. Lipids 43, 887-894.
9. Schwartz GJ, Fu J, Astarita G, et al. (2008) The lipid messenger OEA links dietary fat intake to satiety. Cell Metab 8, 281-288.
10. Terrazzino S, Berto F, Carbonare MD, et al. (2004) Stearoylethanolamide exerts anorexic effects in mice via down-regulation of liver stearoyl-coenzyme A desaturase-1 mRNA expression. FASEB J 18, 1580-1582. (Pubitemid 39561639)
11. Dalle Carbonare M, Del Giudice E, Stecca A, et al. (2008) A saturated N-acylethanolamine other than N-palmitoyl ethanolamine with anti-inflammatory properties: a neglected story. J Neuroendocrinol 20, 26-34. (Pubitemid 351552673)
12. Burstein S (2008) The elmiric acids: biologically active anandamide analogs. Neuropharmacology 55, 1259-1264.
13. Burstein SH & Zurier RB (2009) Cannabinoids, endocannabinoids, and related analogs in inflammation. AAPS J 11, 109-119.
14. Calder PC (2007) Immunomodulation by omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 77, 327-335. (Pubitemid 350198856)
15. Calder PC (2008) The relationship between the fatty acid composition of immune cells and their function. Prostaglandins Leukot Essent Fatty Acids 79, 101-108.
16. Harris WS (2008) n-3 Fatty acids and health: DaVinci's code. Am J Clin Nutr 88, 595-596.
17. Harris WS & Bulchandani D (2006) Why do omega-3 fatty acids lower serum triglycerides? Curr Opin Lipidol 17, 387-393. (Pubitemid 44079475)
18. Russo GL (2009) Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention. Biochem Pharmacol 77, 937-946.
19. Artmann A, Petersen G, Hellgren LI, et al. (2008) Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine. Biochim Biophys Acta 1781, 200-212.
20. Berger A, Crozier G, Bisogno T, et al. (2001) Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets. Proc Natl Acad Sci USA 98, 6402-6406. (Pubitemid 32488249)
21. Bisogno T, Delton-Vandenbroucke I, Milone A, et al. (1999) Biosynthesis and inactivation of N-arachidonoylethanolamine (anandamide) and N-docosahexaenoylethanolamide in bovine retina. Arch Biochem Biophys 370, 300-307. (Pubitemid 29491438)
22. Eckardt K, Sell H, Taube A, et al. (2009) Cannabinoid type 1 receptors in human skeletal muscle cells participate in the negative crosstalk between fat and muscle. Diabetologia 52, 664-674.
23. Balvers MG, Verhoeckx KC, Plastina P, et al. (2010) Docosahexaenoic acid and eicosapentaenoic acid are converted by 3T3-L1 adipocytes to N-acyl ethanolamines with anti-inflammatory properties. Biochim Biophys Acta 1801, 1107-1114.
24. Plastina P, Meijerink J, Vincken J-P, et al. (2009) Selective synthesis of unsaturated N-acylethanolamines by lipase-catalyzed N-acylation of ethanolamine with unsaturated fatty acids. Lett Org Chem 6, 444-447.
25. Lupinacci E, Meijerink J, Vincken JP, et al. (2009) Xanthohumol from hop (Humulus lupulus L.) is an efficient inhibitor of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha release in LPS-stimulated RAW264.7 mouse macrophages and U937 human monocytes. J Agric Food Chem 57, 7274-7281.
26. Green LC, Wagner DA & Glogowski J (1982) Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 126, 131-138. (Pubitemid 13203451)
27. Calder PC (2009) Polyunsaturated fatty acids and inflammatory processes: new twists in an old tale. Biochimie 91, 791-795.
28. Svennerholm L (1968) Distribution and fatty acid composition of phosphoglycerides in normal human brain. J Lipid Res 9, 570-579.
29. Umhau JC, Zhou W, Carson RE, et al. (2009) Imaging incorporation of circulating docosahexaenoic acid into the human brain using positron emission tomography. J Lipid Res 50, 1259-1268.
30. Wall KM, Diersen-Schade D & Innis SM (1994) Plasma and tissue lipids of piglets fed formula containing saturated fatty acids from medium-chain triglycerides with or without fish oil. Am J Clin Nutr 59, 1317-1324. (Pubitemid 24165885)
31. Dallaire P, Bellmann K, Laplante M, et al. (2008) Obese mice lacking inducible nitric oxide synthase are sensitized to the metabolic actions of peroxisome proliferator-activated receptor-gamma agonism. Diabetes 57, 1999-2011.
32. Kuhlencordt PJ, Chen J, Han F, et al. (2001) Genetic deficiency of inducible nitric oxide synthase reduces atherosclerosis and lowers plasma lipid peroxides in apolipoprotein E-knockout mice. Circulation 103, 3099-3104. (Pubitemid 32587858)
33. Ponnuswamy P, Ostermeier E, Schrottle A, et al. (2009) Oxidative stress and compartment of gene expression determine proatherosclerotic effects of inducible nitric oxide synthase. Am J Pathol 174, 2400-2410.
34. Jobgen WS, Fried SK, Fu WJ, et al. (2006) Regulatory role for the arginine-nitric oxide pathway in metabolism of energy substrates. J Nutr Biochem 17, 571-588. (Pubitemid 44205442)
35. Bogdan C (2001) Nitric oxide and the immune response. Nat Immunol 2, 907-916. (Pubitemid 32976162)
36. Weldon SM, Mullen AC, Loscher CE, et al. (2007) Docosahexaenoic acid induces an anti-inflammatory profile in lipopolysaccharide- stimulated human THP-1 macrophages more effectively than eicosapentaenoic acid. J Nutr Biochem 18, 250-258. (Pubitemid 46389578)
37. Sun YX, Tsuboi K, Zhao LY, et al. (2005) Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages. Biochim Biophys Acta 1736, 211-220. (Pubitemid 41423705)
38. Boring L, Gosling J, Cleary M, et al. (1998) Decreased lesion formation in CCR22/2 mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394, 894-897. (Pubitemid 28410911)
39. Gu L, Okada Y, Clinton SK, et al. (1998) Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 2, 275-281. (Pubitemid 128373654)
40. Kanda H, Tateya S, Tamori Y, et al. (2006) MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 116, 1494-1505.
41. Tateya S, Tamori Y, Kawaguchi T, et al. (2010) An increase in the circulating concentration of monocyte chemoattractant protein-1 elicits systemic insulin resistance irrespective of adipose tissue inflammation in mice. Endocrinology 151, 971-979.
42. Zhang M & Fritsche KL (2004) Fatty acid-mediated inhibition of IL-12 production by murine macrophages is independent of PPARgamma. Br J Nutr 91, 733-739. (Pubitemid 38702220)
43. Mickleborough TD, Tecklenburg SL, Montgomery GS, et al. (2009) Eicosapentaenoic acid is more effective than docosahexaenoic acid in inhibiting proinflammatory mediator production and transcription from LPS-induced human asthmatic alveolar macrophage cells. Clin Nutr 28, 71-77.
44. Shi Y & Pestka JJ (2009) Mechanisms for suppression of interleukin-6 expression in peritoneal macrophages from docosahexaenoic acid-fed mice. J Nutr Biochem 20, 358-368.
45. Schmitz G & Ecker J (2008) The opposing effects of n-3 and n-6 fatty acids. Prog Lipid Res 47, 147-155.
46. Serhan CN, Chiang N & Van Dyke TE (2008) Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8, 349-361. (Pubitemid 351595216)
47. Woodward DF, Carling RWC, Cornell CL, et al. (2008) The pharmacology and therapeutic relevance of endocannabinoid derived cyclo-oxygenase (COX)-2 products. Pharmacol Ther 120, 71-80.
48. White PJ & Marette A (2006) Is omega-3 key to unlocking inflammation in obesity? Diabetologia 49, 1999-2001. (Pubitemid 44168464)
49. Watanabe S, Doshi M & Hamazaki T (2003) n-3 Polyunsaturated fatty acid (PUFA) deficiency elevates and n-3 PUFA enrichment reduces brain 2-arachidonoylglycerol level in mice. Prostaglandins Leukot Essent Fatty Acids 69, 51-59. (Pubitemid 37421501)
50. Batetta B, Griinari M, Carta G, et al. (2009) Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats. J Nutr 139, 1495-1501.
51. Bisogno T, Melck D, De Petrocellis L, et al. (1998) Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase. Biochem Biophys Res Commun 248, 515-522. (Pubitemid 28404452)
52. Banni S & Di Marzo V (2010) Effect of dietary fat on endocannabinoids and related mediators: consequences on energy homeostasis, inflammation and mood. Mol Nutr Food Res 54, 82-92.
53. Grundy SM (2006) Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy. Nat Rev Drug Discov 5, 295-309.
54. Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444, 860-867. (Pubitemid 46024993)
55. Nathan C (2008) Epidemic inflammation: pondering obesity. Mol Med 14, 485-492.
56. Shoelson SE, Lee J & Goldfine AB (2006) Inflammation and insulin resistance. J Clin Invest 116, 1793-1801. (Pubitemid 44033299)
57. Elizalde M, Rydén M, Van Harmelen V, et al. (2000) Expression of nitric oxide synthases in subcutaneous adipose tissue of nonobese and obese humans. J Lipid Res 41, 1244-1251. (Pubitemid 30666890)
58. Fujimoto M, Shimizu N, Kunii K, et al. (2005) A role for iNOS in fasting hyperglycemia and impaired insulin signaling in the liver of obese diabetic mice. Diabetes 54, 1340-1348. (Pubitemid 40586662)
59. Engeli S, Janke J, Gorzelniak K, et al. (2004) Regulation of the nitric oxide system in human adipose tissue. J Lipid Res 45, 1640-1648. (Pubitemid 39296203)
60. Sugita H, Kaneki M, Tokunaga E, et al. (2002) Inducible nitric oxide synthase plays a role in LPS-induced hyperglycemia and insulin resistance. Am J Physiol Endocrinol Metab 282, E386-E394. (Pubitemid 34654809)
61. Philip CC (2008) Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. Mol Nutr Food Res 52, 885-897.